Pharming Group N.V.
NASDAQ:PHAR · NASDAQ Global Market
+$0.28 today
Vol 0.00M · Avg 0.01M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+24.75%
Period High
$21.18
Period Low
$9.80
Latest
$12.87
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Tango Therapeutics, Inc.
NASDAQ:TNGX
$3.52B
Septerna, Inc.
NASDAQ:SEPN
$1.58B
Mind Medicine (MindMed) Inc.
MNMD
$1.56B
Fortrea Holdings Inc.
NASDAQ:FTRE
$1.44B
Palvella Therapeutics, Inc.
NASDAQ:PVLA
$1.32B
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX
$1.27B
EyePoint Pharmaceuticals, Inc.
NASDAQ:EYPT
$1.13B
Arbutus Biopharma Corporation
NASDAQ:ABUS
$884.97M
Kura Oncology, Inc.
NASDAQ:KURA
$857.56M
ProKidney Corp.
NASDAQ:PROK
$261.29M
What is the latest PHAR filing?
The latest filing shown is 6-K dated Jun 4, 2026.
How many recent filings does PHAR have?
Intrinsic Alpha currently shows 20 recent filings for PHAR.
Explore More
Continue the stock analysis
Jump to another research area for this company.